<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Lou TL</submitter><pubmed_abstract>&lt;i>Tetrastigma hemsleyanum&lt;/i> Diels &amp; Gilg (&lt;i>T. hemsleyanum&lt;/i>) has attracted much attention due to its ability on pneumonia, bronchitis, and immune-related diseases, while its functional components and underlying mechanism of action on pneumonia have not been fully elucidated. Herein, we used a systematic network pharmacology approach to explore the action mechanism of &lt;i>T. hemsleyanum&lt;/i> leaf in the treatment of pneumonia. In this study, the results of network pharmacology demonstrated that there were 34 active components and 80 drug-disease targets in &lt;i>T. hemsleyanum&lt;/i> leaf, which were strongly in connection with signal transduction, inflammatory response, and the oxidation-reduction process. Subsequently, a mouse model of pneumonia induced by &lt;i>Pseudomonas aeruginosa&lt;/i> (&lt;i</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>587850</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8326761</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Extract From &lt;i>Tetrastigma hemsleyanum&lt;/i> Leaf Alleviates &lt;i>Pseudomonas aeruginosa&lt;/i> Lung Infection: Network Pharmacology Analysis and Experimental Evidence.</pubmed_title><pmcid>PMC8326761</pmcid><pubmed_authors>Ji T</pubmed_authors><pubmed_authors>Peng X</pubmed_authors><pubmed_authors>Ji WW</pubmed_authors><pubmed_authors>Li SM</pubmed_authors><pubmed_authors>Lou TL</pubmed_authors><pubmed_authors>Yuan LX</pubmed_authors><pubmed_authors>Shi QY</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Wang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Extract From &lt;i>Tetrastigma hemsleyanum&lt;/i> Leaf Alleviates &lt;i>Pseudomonas aeruginosa&lt;/i> Lung Infection: Network Pharmacology Analysis and Experimental Evidence.</name><description>&lt;i>Tetrastigma hemsleyanum&lt;/i> Diels &amp; Gilg (&lt;i>T. hemsleyanum&lt;/i>) has attracted much attention due to its ability on pneumonia, bronchitis, and immune-related diseases, while its functional components and underlying mechanism of action on pneumonia have not been fully elucidated. Herein, we used a systematic network pharmacology approach to explore the action mechanism of &lt;i>T. hemsleyanum&lt;/i> leaf in the treatment of pneumonia. In this study, the results of network pharmacology demonstrated that there were 34 active components and 80 drug-disease targets in &lt;i>T. hemsleyanum&lt;/i> leaf, which were strongly in connection with signal transduction, inflammatory response, and the oxidation-reduction process. Subsequently, a mouse model of pneumonia induced by &lt;i>Pseudomonas aeruginosa&lt;/i> (&lt;i</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-19T20:40:15.984Z</modification><creation>2022-02-11T02:56:03.973Z</creation></dates><accession>S-EPMC8326761</accession><cross_references><pubmed>34349638</pubmed><doi>10.3389/fphar.2021.587850</doi></cross_references></HashMap>